Comparative evaluation and preference of MixPro® versus Mix2Vial® reconstitution devices among people with haemophilia and caregivers

People with haemophilia (PwH) require frequent infusions with plasma-derived or recombinant coagulation factors to help prevent and treat acute bleeding episodes. This ‘replacement therapy’ can be administered at home by PwH or their caregivers using a drug reconstitution device. MixPro® and Mix2Via...

Full description

Bibliographic Details
Main Authors: Hansen Jon Ulrich, Percier Cléa, Damgaard-Rasmussen Henrik, Palmer Katherine
Format: Article
Language:English
Published: Sciendo 2022-10-01
Series:The Journal of Haemophilia Practice
Subjects:
Online Access:https://doi.org/10.2478/jhp-2022-0012
_version_ 1811153980184592384
author Hansen Jon Ulrich
Percier Cléa
Damgaard-Rasmussen Henrik
Palmer Katherine
author_facet Hansen Jon Ulrich
Percier Cléa
Damgaard-Rasmussen Henrik
Palmer Katherine
author_sort Hansen Jon Ulrich
collection DOAJ
description People with haemophilia (PwH) require frequent infusions with plasma-derived or recombinant coagulation factors to help prevent and treat acute bleeding episodes. This ‘replacement therapy’ can be administered at home by PwH or their caregivers using a drug reconstitution device. MixPro® and Mix2Vial® are two such devices.
first_indexed 2024-04-09T14:09:54Z
format Article
id doaj.art-76e98e87ebde4fb5be988f738f5012ad
institution Directory Open Access Journal
issn 2055-3390
language English
last_indexed 2024-04-09T14:09:54Z
publishDate 2022-10-01
publisher Sciendo
record_format Article
series The Journal of Haemophilia Practice
spelling doaj.art-76e98e87ebde4fb5be988f738f5012ad2023-05-06T15:31:52ZengSciendoThe Journal of Haemophilia Practice2055-33902022-10-019110311710.2478/jhp-2022-0012Comparative evaluation and preference of MixPro® versus Mix2Vial® reconstitution devices among people with haemophilia and caregiversHansen Jon Ulrich0Percier Cléa1Damgaard-Rasmussen Henrik2Palmer Katherine3Novo Nordisk, Hillerød, Capital Region, DenmarkNovo Nordisk, Zürich, SwitzerlandNovo Nordisk, Hillerød, Capital Region, DenmarkPhoenix Marketing International, Rhinebeck, NY, USAPeople with haemophilia (PwH) require frequent infusions with plasma-derived or recombinant coagulation factors to help prevent and treat acute bleeding episodes. This ‘replacement therapy’ can be administered at home by PwH or their caregivers using a drug reconstitution device. MixPro® and Mix2Vial® are two such devices.https://doi.org/10.2478/jhp-2022-0012haemophiliacoagulation factordevicepatientcaregiverexperience
spellingShingle Hansen Jon Ulrich
Percier Cléa
Damgaard-Rasmussen Henrik
Palmer Katherine
Comparative evaluation and preference of MixPro® versus Mix2Vial® reconstitution devices among people with haemophilia and caregivers
The Journal of Haemophilia Practice
haemophilia
coagulation factor
device
patient
caregiver
experience
title Comparative evaluation and preference of MixPro® versus Mix2Vial® reconstitution devices among people with haemophilia and caregivers
title_full Comparative evaluation and preference of MixPro® versus Mix2Vial® reconstitution devices among people with haemophilia and caregivers
title_fullStr Comparative evaluation and preference of MixPro® versus Mix2Vial® reconstitution devices among people with haemophilia and caregivers
title_full_unstemmed Comparative evaluation and preference of MixPro® versus Mix2Vial® reconstitution devices among people with haemophilia and caregivers
title_short Comparative evaluation and preference of MixPro® versus Mix2Vial® reconstitution devices among people with haemophilia and caregivers
title_sort comparative evaluation and preference of mixpro r versus mix2vial r reconstitution devices among people with haemophilia and caregivers
topic haemophilia
coagulation factor
device
patient
caregiver
experience
url https://doi.org/10.2478/jhp-2022-0012
work_keys_str_mv AT hansenjonulrich comparativeevaluationandpreferenceofmixproversusmix2vialreconstitutiondevicesamongpeoplewithhaemophiliaandcaregivers
AT percierclea comparativeevaluationandpreferenceofmixproversusmix2vialreconstitutiondevicesamongpeoplewithhaemophiliaandcaregivers
AT damgaardrasmussenhenrik comparativeevaluationandpreferenceofmixproversusmix2vialreconstitutiondevicesamongpeoplewithhaemophiliaandcaregivers
AT palmerkatherine comparativeevaluationandpreferenceofmixproversusmix2vialreconstitutiondevicesamongpeoplewithhaemophiliaandcaregivers